Your browser doesn't support javascript.
loading
Development and validation of an automated radiomic CT signature for detecting COVID-19
Julien Guiot; Akshayaa Vaidyanathan; Louis Deprez; Fadila Zerka; Denis Danthine; Anne-Noelle Frix; Marie Thys; Monique Henket; Gregory Canivet; Stephane Mathieu; Eva Eftaxia; Philippe Lambin; Nathan Tsoutzidis; Benjamin Miraglio; Sean Walsh; Michel Moutschen; Renaud Louis; Paul Meunier; Wim Vos; Ralph Leijenaar; Pierre Lovinfosse.
Affiliation
  • Julien Guiot; Department of Pneumology, University Hospital of Liege, Liege, Belgium
  • Akshayaa Vaidyanathan; Oncoradiomics SA, Liege, Belgium, The D-Lab, Department of Precision Medicine, Department of Nuclear Medicine, GROW School for Oncology, Maastricht University,
  • Louis Deprez; Department of Radiology, University Hospital of Liege, Liege, Belgium
  • Fadila Zerka; Oncoradiomics SA, Liege, Belgium, The D-Lab, Department of Precision Medicine, Department of Nuclear Medicine, GROW School for Oncology, Maastricht University,
  • Denis Danthine; Department of Radiology, University Hospital of Liege, Liege, Belgium
  • Anne-Noelle Frix; Department of Pneumology, University Hospital of Liege, Liege, Belgium
  • Marie Thys; Department of Medico-Economic Information, University Hospital of Liege, Liege, Belgium
  • Monique Henket; Department of Pneumology, University Hospital of Liege, Liege, Belgium
  • Gregory Canivet; Department of Computer Applications, University Hospital of Liege, Liege, Belgium
  • Stephane Mathieu; Department of Computer Applications, University Hospital of Liege, Liege, Belgium
  • Eva Eftaxia; Department of Radiology, University Hospital of Liege, Liege, Belgium
  • Philippe Lambin; The D-Lab, Department of Precision Medicine, Department of Nuclear Medicine, GROW School for Oncology, Maastricht University, Maastricht, The Netherlands
  • Nathan Tsoutzidis; Oncoradiomics SA, Liege, Belgium
  • Benjamin Miraglio; Oncoradiomics SA, Liege, Belgium
  • Sean Walsh; Oncoradiomics SA, Liege, Belgium
  • Michel Moutschen; Department of Infectious Diseases, University Hospital of Liege, Liege, Belgium Michel
  • Renaud Louis; Department of Pneumology, University Hospital of Liege, Liege, Belgium
  • Paul Meunier; Department of Radiology, University Hospital of Liege, Liege, Belgium
  • Wim Vos; Oncoradiomics SA, Liege, Belgium
  • Ralph Leijenaar; Oncoradiomics SA, Liege, Belgium
  • Pierre Lovinfosse; Department of Nuclear Medicine and Oncological Imaging, University Hospital of Liege, Liege, Belgium
Preprint in English | medRxiv | ID: ppmedrxiv-20082966
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
BackgroundThe coronavirus disease 2019 (COVID-19) outbreak has reached pandemic status. Drastic measures of social distancing are enforced in society and healthcare systems are being pushed to and over their limits. ObjectivesTo develop a fully automatic framework to detect COVID-19 by applying AI to chest CT and evaluate validation performance. MethodsIn this retrospective multi-site study, a fully automated AI framework was developed to extract radiomics features from volumetric chest CT exams to learn the detection pattern of COVID-19 patients. We analysed the data from 181 RT-PCR confirmed COVID-19 patients as well as 1200 other non-COVID-19 control patients to build and assess the performance of the model. The datasets were collected from 2 different hospital sites of the CHU Liege, Belgium. Diagnostic performance was assessed by the area under the receiver operating characteristic curve (AUC), sensitivity and specificity. Results1381 patients were included in this study. The average age was 64.4{+/-}15.8 and 63.8{+/-}14.4 years with a gender balance of 56% and 52% male in the COVID-19 and control group, respectively. The final curated dataset used for model construction and validation consisted of chest CT scans of 892 patients. The model sensitivity and specificity for detecting COVID-19 in the test set (training 80% and test 20% of patients) were 78.94% and 91.09%, respectively, with an AUC of 0.9398 (95% CI 0.875-1). The negative predictive value of the algorithm was found to be larger than 97%. ConclusionsBenchmarked against RT-PCR confirmed cases of COVID-19, our AI framework can accurately differentiate COVID-19 from routine clinical conditions in a fully automated fashion. Thus, providing rapid accurate diagnosis in patients suspected of COVID-19 infection, facilitating the timely implementation of isolation procedures and early intervention.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Experimental_studies / Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Experimental_studies / Observational study / Prognostic study Language: English Year: 2020 Document type: Preprint
...